This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauderdale, T.-L.
Right arrow Articles by Chapin, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauderdale, T.-L.
Right arrow Articles by Chapin, K.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 1999, p. 2223-2229, Vol. 37, No. 7
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Comparison of the PACE 2 Assay, Two Amplification Assays, and Clearview EIA for Detection of Chlamydia trachomatis in Female Endocervical and Urine Specimens

Tsai-Ling Lauderdale,1 Lenore Landers,1 Ian Thorneycroft,2 and Kimberle Chapin1,*

Departments of Pathology1 and Obstetrics and Gynecology,2 University of South Alabama, Mobile, Alabama

Received 28 December 1998/Returned for modification 8 February 1999/Accepted 23 March 1999

Screening for sexually transmitted diseases (STDs) in a greater proportion of sexually active patients has become an accepted protocol by most health care providers. The purpose of this study was to compare the current test methods for detection of Chlamydia trachomatis used at the University of South Alabama, the PACE 2 assay (Gen-Probe) and the Clearview EIA (Wampole Laboratories), with two amplification technologies, the AMP CT (Gen-Probe) and LCx (Abbott) assays. In addition, a number of demographic parameters were ascertained by asking questions at the time of examination as well as for health care provider concerns and preferences. One urine and four endocervical swab specimens were collected in random order from 787 female patients attending one of four obstetrics-gynecology clinics. Eighty-seven percent of patients had no STD-related symptoms. Patients were considered positive for C. trachomatis if three or more assays (swab and/or urine) were positive. Abbott and Gen-Probe confirmed discrepant results by alternate amplified assays. A total of 66 true-positive specimens were detected by use of the combination of endocervical swabs and urine specimens. After discrepant analysis, sensitivities for endocervical swab specimens for the EIA and the PACE 2, LCx, and AMP CT assays were 50, 81, 97, and 100%, respectively. Sensitivities for the LCx and AMP CT assays with urine specimens were 98 and 81%, respectively. The prevalence of C. trachomatis was 8.4%, as determined by amplification technology. Overall, the amplification technologies were the most sensitive methods with either swab (AMP CT assay) or urine (LCx assay) specimens. The PACE 2 assay offered the advantage of a simpler and less expensive assay with acceptable sensitivity. The clearview CT EIA, while yielding a rapid in-office result, had unacceptably low sensitivity. The wide variation in performance with amplification assays with urine specimens as reported in both this study and the literature obviates the need to clarify optimal parameters for this specimen type.

* Corresponding author. Present address: Department of Laboratory Medicine, Lahey Clinic, 41 Mall Rd., Burlington, MA 01805. Phone: (781) 744-8936. Fax: (781) 744-5208. E-mail: kimberle.c.chapin{at}lahey.org.

Journal of Clinical Microbiology, July 1999, p. 2223-2229, Vol. 37, No. 7
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sabido, M., Hernandez, G., Gonzalez, V., Valles, X., Montoliu, A., Figuerola, J., Isern, V., Vinado, B., Figueroa, L., Casabona, J. (2009). Clinic-Based Evaluation of a Rapid Point-of-Care Test for Detection of Chlamydia trachomatis in Specimens from Sex Workers in Escuintla, Guatemala. J. Clin. Microbiol. 47: 475-476 [Abstract] [Full Text]  
  • Yang, J. L., Hong, K. C., Schachter, J., Moncada, J., Lekew, T., House, J. I., Zhou, Z., Neuwelt, M. D., Rutar, T., Halfpenny, C., Shah, N., Whitcher, J. P., Lietman, T. M. (2009). Detection of Chlamydia trachomatis Ocular Infection in Trachoma-Endemic Communities by rRNA Amplification. IOVS 50: 90-94 [Abstract] [Full Text]  
  • Mahilum-Tapay, L., Laitila, V., Wawrzyniak, J. J, Lee, H. H, Alexander, S., Ison, C., Swain, A., Barber, P., Ushiro-Lumb, I., Goh, B. T (2007). New point of care Chlamydia Rapid Test bridging the gap between diagnosis and treatment: performance evaluation study. BMJ 335: 1190-1194 [Abstract] [Full Text]  
  • Saison, F., Mahilum-Tapay, L., Michel, C.-E. E., Buttress, N. D., Nadala, E. C. B. Jr., Magbanua, J. P. V., Harding-Esch, E. M., Villaruel, M. O., Canong, L., Celis, R. L., Lee, H. H. (2007). Prevalence of Chlamydia trachomatis Infection among Low- and High-Risk Filipino Women and Performance of Chlamydia Rapid Tests in Resource-Limited Settings. J. Clin. Microbiol. 45: 4011-4017 [Abstract] [Full Text]  
  • Yang, J. L, Schachter, J., Moncada, J., Habte, D., Zerihun, M., House, J. I, Zhou, Z., Hong, K. C, Maxey, K., Gaynor, B. D, Lietman, T. M (2007). Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br J Ophthalmol 91: 293-295 [Abstract] [Full Text]  
  • Yin, Y-P, Peeling, R W, Chen, X-S, Gong, K-L, Zhou, H, Gu, W-M, Zheng, H-P, Wang, Z-S, Yong, G, Cao, W-L, Shi, M-Q, Wei, W-H, Dai, X-Q, Gao, X, Chen, Q, Mabey, D (2006). Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China. Sex. Transm. Infect. 82: v33-v37 [Abstract] [Full Text]  
  • Solomon, A. W., Peeling, R. W., Foster, A., Mabey, D. C. W. (2004). Diagnosis and Assessment of Trachoma. Clin. Microbiol. Rev. 17: 982-1011 [Abstract] [Full Text]  
  • Orroth, K K, Korenromp, E L, White, R G, Changalucha, J, de Vlas, S J, Gray, R H, Hughes, P, Kamali, A, Ojwiya, A, Serwadda, D, Wawer, M J, Hayes, R J, Grosskurth, H (2003). Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors. Sex. Transm. Infect. 79: 98-105 [Abstract] [Full Text]  
  • Land, S., Tabrizi, S., Gust, A., Johnson, E., Garland, S., Dax, E. M. (2002). External Quality Assessment Program for Chlamydia trachomatis Diagnostic Testing by Nucleic Acid Amplification Assays. J. Clin. Microbiol. 40: 2893-2896 [Abstract] [Full Text]  
  • Loeffelholz, M. J., Jirsa, S. J., Teske, R. K., Woods, J. N. (2001). Effect of Endocervical Specimen Adequacy on Ligase Chain Reaction Detection of Chlamydia trachomatis. J. Clin. Microbiol. 39: 3838-3841 [Abstract] [Full Text]  
  • Chernesky, M., Jang, D., Copes, D., Patel, J., Petrich, A., Biers, K., Sproston, A., Kapala, J. (2001). Comparison of a Polymer Conjugate-Enhanced Enzyme Immunoassay to Ligase Chain Reaction for Diagnosis of Chlamydia trachomatis in Endocervical Swabs. J. Clin. Microbiol. 39: 2306-2307 [Abstract] [Full Text]  
  • Johnson, S. J., Green, D. H., Reed, D. A., Wood, L. S. (2001). Semiautomation of Nucleic Acid-based Assays for Chlamydia trachomatis and Neisseria gonorrhoeae,. Clin. Chem. 47: 760-763 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»